Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 29, Issue 4, Pages 924-930
Publisher
Oxford University Press (OUP)
Online
2018-01-06
DOI
10.1093/annonc/mdy004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overall response rate (ORR) in STEAM, a randomized, open-label, phase 2 trial of sequential and concurrent FOLFOXIRI-bevacizumab (BEV) vs FOLFOX-BEV for the first-line (1L) treatment (tx) of patients (pts) with metastatic colorectal cancer (mCRC).
- (2016) Johanna C. Bendell et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate cancer: net survival and cause-specific survival rates after multiple imputation
- (2015) Adeline Morisot et al. BMC Medical Research Methodology
- FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
- (2015) Chiara Cremolini et al. LANCET ONCOLOGY
- Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a meta-analysis
- (2015) Hao Cheng et al. Scientific Reports
- Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
- (2014) Wei-Kai Xiao et al. BMC CANCER
- Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
- (2014) Fotios Loupakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Australian translational Study to evaluate the prognostic role of inflammatory markers in patients with metastatic ColorEctal caNcer Treated with bevacizumab (Avastin™) [ASCENT]
- (2013) Stephen Clarke et al. BMC CANCER
- Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy
- (2013) Suee Lee et al. BMC CANCER
- Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis
- (2013) Mu-Xing Li et al. INTERNATIONAL JOURNAL OF CANCER
- Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature
- (2012) Alexander Stein et al. BMC CANCER
- The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer
- (2012) Donald C. McMillan CANCER TREATMENT REVIEWS
- Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment
- (2012) Takashi Motomura et al. JOURNAL OF HEPATOLOGY
- Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy
- (2012) Manabu Kaneko et al. ONCOLOGY
- Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
- (2011) W Chua et al. BRITISH JOURNAL OF CANCER
- Neutrophil-Lymphocyte Ratio as a Predictor of Adverse outcomes of Acute Pancreatitis
- (2011) Basem Azab et al. PANCREATOLOGY
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Cancer and Inflammation: Implications for Pharmacology and Therapeutics
- (2010) F Balkwill et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Editorial: In this Issue
- (2010) Adrian Bot INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy
- (2009) Yoji Kishi et al. ANNALS OF SURGICAL ONCOLOGY
- Systemic inflammation, nutritional status and survival in patients with cancer
- (2009) Donald C McMillan CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
- (2009) Campbell SD Roxburgh et al. Future Oncology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now